Pharmaceuticals

Thu, 04/30/2009 - 10:29

Collaboration and focus key to R & D success - CK Life Sciences

by Sarah Wu

Dr. Melvin Toh, vice president of the pharmaceutical development department in CK Life Sciences Int'l (Holdings) Inc., recently revealed to Interfax the company's research and development strategies.

For a life sciences company to succeed, it is essential to have a clear and focused business model.
Dr. Melvin Toh, vice president of CK Life Sciences' pharmaceutical development department

Shanghai. April 30. INTERFAX-CHINA - A clear focus coupled with extensive collaboration is at the core of CK Life Sciences Int'l (Holdings) Inc.'s pharmaceutical research and development (R & D) strategies, Dr. Melvin Toh, vice president of CK Life Sciences' pharmaceutical development department, told Interfax.

This article is only accessible to Interfax subscribers. To gain access to this article, as well similar in-depth articles and industry-specific content, please contact our sales staff by telephone (+852 2537 2262) .

Start free trial NOW